Clinical trial
Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
NCT06416345 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease
- Lead sponsor
- Amsterdam UMC, location VUmc
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 22, 2025
- Completion date
- December 1, 2027
- Enrollment
- 84 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.